NDC properties for "Simlandi 40 MG per 0.4 ML Prefilled Syringe" (RxCUI 2688827)
About this data
The tables show NDC propoerties for Simlandi 40 MG per 0.4 ML Prefilled Syringe with the RxCUI 2688827
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Simlandi 40 MG per 0.4 ML Prefilled Syringe (RxCUI 2688827)
| BLA | BLA761299 |
|---|---|
| RxCUI | 2688827 |
| SPL_SET_ID | 12f609c9-2088-bb05-e063-6394a90a9ecc |
| Prescribable Synonym | Simlandi 40 MG in 0.4 ML Prefilled Syringe |
| RXNAV_STR | Simlandi 40 MG per 0.4 ML Prefilled Syringe |
| RxNorm Name | 0.4 ML adalimumab-ryvk 100 MG/ML Prefilled Syringe [Simlandi] |
| RxNorm Synonym | Simlandi 40 MG per 0.4 ML Prefilled Syringe |
| Related queries | Interactions (for RxCUI 2688827) |
NDC Properties
NDC Item 51759041222
| NDC 9 | 51759-412 |
|---|---|
| NDC 10 | 51759-412-22 |
| NDC Item | 51759041222 |
| Packaging | 2 KIT in 1 CARTON (51759-412-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-624-31) * .4 mL in 1 POUCH |
| BLA | BLA761299 |
| FDA SPL set id | 800492 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-07-31 |
| Marketing status | active |
| Related queries | Properties for NDC 9 51759-412 |
NDC Item 51759062431
| NDC 9 | 51759-624 |
|---|---|
| NDC 10 | 51759-624-31 |
| NDC Item | 51759062431 |
| Packaging | 0.4 mL in 1 SYRINGE |
| FDA SPL set id | 800492 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 51759-624 |
NDC Item 51759041222
| NDC 9 | 51759-412 |
|---|---|
| NDC 10 | 51759-412-22 |
| NDC Item | 51759041222 |
| Packaging | 2 KIT in 1 CARTON (51759-412-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-624-31) * .4 mL in 1 POUCH |
| BLA | BLA761299 |
| FDA SPL set id | 800492 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-07-31 |
| Marketing status | active |
| Related queries | Properties for NDC 9 51759-412 |
NDC Item 51759062431
| NDC 9 | 51759-624 |
|---|---|
| NDC 10 | 51759-624-31 |
| NDC Item | 51759062431 |
| Packaging | 0.4 mL in 1 SYRINGE |
| FDA SPL set id | 800492 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Related queries | Properties for NDC 9 51759-624 |